Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
Authors
Keywords
Immunotherapy, Immune-related adverse event, Pneumonitis, Radiomics
Journal
INVESTIGATIONAL NEW DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2017-10-27
DOI
10.1007/s10637-017-0524-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy
- (2017) Jarushka Naidoo et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology
- (2016) Don S. Dizon et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiomics: Images Are More than Pictures, They Are Data
- (2016) Robert J. Gillies et al. RADIOLOGY
- DeepAnomaly: Combining Background Subtraction and Deep Learning for Detecting Obstacles and Anomalies in an Agricultural Field
- (2016) Peter Christiansen et al. SENSORS
- Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
- (2016) Mizuki Nishino et al. JAMA Oncology
- A Comparative Evaluation of Unsupervised Anomaly Detection Algorithms for Multivariate Data
- (2016) Markus Goldstein et al. PLoS One
- Lung Texture in Serial Thoracic Computed Tomography Scans: Correlation of Radiomics-based Features With Radiation Therapy Dose and Radiation Pneumonitis Development
- (2015) Alexandra Cunliffe et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Toxicities of Immunotherapy for the Practitioner
- (2015) Jeffrey S. Weber et al. JOURNAL OF CLINICAL ONCOLOGY
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
- (2015) Michael A. Postow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti–PD-1–Related Pneumonitis during Cancer Immunotherapy
- (2015) Mizuki Nishino et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Mitigating the toxic effects of anticancer immunotherapy
- (2014) Tara C. Gangadhar et al. Nature Reviews Clinical Oncology
- Erratum: Corrigendum: Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
- (2014) Hugo J.W.L. Aerts et al. Nature Communications
- mRMRe: an R package for parallelized mRMR ensemble feature selection
- (2013) Nicolas De Jay et al. BIOINFORMATICS
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now